BioNTech SE (BNTX) Inventory Average (2019 - 2025)
BioNTech SE (BNTX) posted Inventory Average of $196.4 million for Q4 2025, down 25.2% sequentially from $262.5 million in Q3 2025, and down 38.21% YoY from $317.8 million in Q4 2024.
BioNTech SE (BNTX) Inventory Average (2019 - 2025) Analysis & Trends
BioNTech SE has reported Inventory Average for 6 years, with the latest figure at $196.4 million in Q4 2025.
- Quarterly Inventory Average fell 38.21% year-over-year to $196.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $196.4 million (down 38.21% YoY) and the FY2025 annual result came in at $213.9 million, down 37.78% from the prior year.
- Inventory Average eased to $196.4 million in Q4 2025 per BNTX's latest filing, from $262.5 million in the prior quarter.
- Over five years, Inventory Average peaked at $545.2 million in Q1 2022 and troughed at $126.8 million in Q1 2021.
- A 5-year average of $357.8 million and a median of $370.7 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 329.91% in 2022, then tumbled 38.21% in 2025.
- Over 5 years, Inventory Average stood at $126.8 million in 2021, then jumped by 194.04% to $372.9 million in 2022, then grew by 12.29% to $418.7 million in 2023, then slipped by 24.1% to $317.8 million in 2024, then slumped by 38.21% to $196.4 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $196.4 million, $262.5 million, and $264.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 196.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 196.36 Mn |
| Sep 30, 2025 | 262.50 Mn |
| Jun 30, 2025 | 264.37 Mn |
| Mar 31, 2025 | 285.17 Mn |
| Dec 31, 2024 | 317.80 Mn |
| Sep 30, 2024 | 349.56 Mn |
| Jun 30, 2024 | 370.74 Mn |
| Mar 31, 2024 | 380.05 Mn |
| Dec 31, 2023 | 418.70 Mn |
| Sep 30, 2023 | 470.67 Mn |
| Jun 30, 2023 | 472.01 Mn |
| Mar 31, 2023 | 451.85 Mn |
| Dec 31, 2022 | 372.87 Mn |
| Sep 30, 2022 | 344.80 Mn |
| Jun 30, 2022 | 453.92 Mn |
| Mar 31, 2022 | 545.17 Mn |
| Mar 31, 2021 | 126.81 Mn |
| Dec 31, 2019 | 12.53 Mn |